4-((4-bromobenzyl)oxy)aniline | 13103-55-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 4-((4-bromobenzyl)oxy)aniline
• 英文别名: 4-[(4-Bromophenyl)methoxy]aniline
• CAS: 13103-55-4
• 化学式: C₁₃H₁₂BrNO
• mdl: MFCD08753568
• 分子量: 278.148
• InChiKey: SXGCGAADZHRHDP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-((4-bromobenzyl)oxy)aniline 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 10-(4-((4-bromobenzyl)oxy)phenyl)-2,4-dioxo-2,3,4,10-tetrahydropyrimido[4,5-b] quinoline-8-carbonitrile
  参考文献：
  名称：

  Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide

  摘要：

  Topoisomerase II (TOP2) poisons as anticancer drugs work by trapping TOP2 cleavage complexes (TOP2cc) to generate DNA damage. Repair of such damage by tyrosyl DNA phosphodiesterase 2 (TDP2) could render cancer cells resistant to TOP2 poisons. Inhibiting TDP2, thus, represents an attractive mechanism-based chemosensitization approach. Currently known TDP2 inhibitors lack cellular potency and/or permeability. We report herein two novel subtypes of the deazaflavin TDP2 inhibitor core. By introducing an additional phenyl ring to the N-10 phenyl ring (subtype 11) or to the N-3 site of the deazaflavin scaffold (subtype 12), we have generated novel analogues with considerably improved biochemical potency and/or permeability. Importantly, many analogues of both subtypes, particularly compounds 11a, 11e, 12a, 12b, and 12h, exhibited much stronger cancer cell sensitizing effect than the best previous analogue 4a toward the treatment with etoposide, suggesting that these analogues could serve as effective cellular probes.

  DOI：

  10.1021/acs.jmedchem.9b00274
• 作为产物：
  描述：

  对硝基苯酚 在 盐酸 、 tin 、 potassium carbonate 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 6.0h， 生成 4-((4-bromobenzyl)oxy)aniline
  参考文献：
  名称：

  叶绿素 b 修饰的 TiO2 纳米颗粒用于可见光诱导光催化合成新型四氢喹啉衍生物

  摘要：

  利用可见光驱动有机反应作为有机化合物合成的可持续技术最近受到了极大的关注。在本研究中，使用3-氨基丙基三乙氧基硅烷(APTES)作为偶联剂将从菠菜中提取的叶绿素b (Ch b )固定在TiO 2纳米粒子的表面上。含镁叶绿素修饰的TiO 2纳米颗粒通过染料敏化将吸收范围从紫外光范围拓宽至可见光范围。通过FT-IR、XRD、FE-SEM、UV-Vis、TGA、 PL、EDX和XPS对制备的光催化剂（Ch b /APTES/TiO 2 ）进行了表征。Ch b /APTES/TiO 2在N,N-二甲基苯胺和4-溴-N ,N-二甲基苯胺与1-(4-烷氧基苯基)-1 H-吡咯-2直接环化中的单电子转移(SET)反应表现出高效率和可重复使用性， 5-二酮衍生物在可见光照射下在环境温度下以高产率获得新的四氢喹啉骨架。使用1 HNMR、13 CNMR、FT-IR 和 CHN 分析对合成的四氢喹啉衍生物进行了表征。这项工作揭示了通过调整

  DOI：

  10.1016/j.mcat.2023.113338

文献信息

• Natural Product Neopeltolide as a Cytochrome <i>bc</i>₁ Complex Inhibitor: Mechanism of Action and Structural Modification
  作者：Xiao-Lei Zhu、Rui Zhang、Qiong-You Wu、Yong-Jun Song、Yu-Xia Wang、Jing-Fang Yang、Guang-Fu Yang

  DOI：10.1021/acs.jafc.8b06195

  日期：2019.3.13

  chemical structure of neopeltolide, leading to the synthesis of a series of new neopeltolide derivatives with much simpler chemical structures. The calculated binding energies (ΔGcal) of the newly synthesized analogues correlated very well (R2 = 0.90) with their experimental binding free energies (ΔGexp), which confirmed that the computational protocol was reliable. Compound 45, bearing a diphenyl ether

  从天然新科科动物的深水海绵标本中分离出海洋天然产物新科植物内酯。新pelolide已被证明是线粒体呼吸链中细胞色素bc 1复合物的新型抑制剂。然而，其详细的抑制机制仍是未知的。另外，由于新鸟苷内酯的化学结构非常复杂，因此很难合成。在当前的工作中，通过结合分子对接，分子动力学模拟和分子力学泊松-玻尔兹曼表面积计算，首次确定了新去内酯的结合模式，这表明新去内酯是bc 1的Q o抑制剂。复杂的。然后，根据抑制剂-蛋白质相互作用分析的指导，进行了结构修饰，目的在于简化新pelolide的化学结构，从而合成了一系列具有更简单化学结构的新neopeltolide衍生物。计算出的新合成类似物的结合能（ΔG cal）与它们的实验结合自由能（ΔG exp）具有很好的相关性（R 2 = 0.90 ），这证实了该计算方案是可靠的。具有二苯醚片段的化合物45已成功设计并合成为最有效的候选物（IC 50（＝ 12n
• COMPOUNDS FOR CANCER CHEMOTHERAPEUTIC SENSITIZATION
  申请人：Regents of the University of Minnesota

  公开号：US20190240244A1

  公开（公告）日：2019-08-08

  The invention provides a compound of formula (I), (II) or (III): wherein R 1 , R 2 , R 3 , R 4 and R 5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), (II) or (III). The compounds and compositions are useful as chemotherapeutic sensitizing agents.

  本发明提供了一种公式(I)、(II)或(III)的化合物： 其中R1、R2、R3、R4和R5具有说明书中描述的任何值，以及包含公式(I)、(II)或(III)的化合物的组合物。这些化合物和组合物作为化学治疗增敏剂是有用的。
• Design, synthesis, and biological evaluation of N-(4-substituted)-3-phenylisoxazolo[5,4–d]pyrimidin-4-amine derivatives as apoptosis-inducing cytotoxic agents
  作者：Nikhil Baliram Gaikwad、Sapana Bansod、Alekhya Mara、Ramana Garise、Nanduri Srinivas、Chandraiah Godugu、Venkata Madhavi Yaddanapudi

  DOI：10.1016/j.bmcl.2021.128294

  日期：2021.10

  incorporating the important pharmacophoric features of 4-aminopyrimidine and phenyl isoxazole scaffold which is renowned for its BET inhibition activity. The designed molecules were synthesized and evaluated with the NCI-60 cell line panel. Examination by NCI-60 cell lines at single-dose and the five-dose study showed that compound 10h exhibited promising growth inhibitory effects with GI50 values on

  新的3 phenylisoxazolo [5,4的文库d ]嘧啶（8 - 10）的基于结合有重要的药效的支架杂交技术设计设有4氨基嘧啶和苯基异恶唑骨架，其以其BET抑制活性。设计的分子是用 NCI-60 细胞系面板合成和评估的。NCI-60 细胞系在单剂量和五剂量研究中的检查表明，化合物10h与 GI 50表现出有希望的生长抑制作用各种癌细胞系的值，例如 HCT-15（结肠癌）-0.0221 μM、MDA-MB-435（黑色素瘤）- 0.0318 μM、SNB-75（CNS 癌）-0.0263 μM 和 MCF7（乳腺癌）-0.0372微米。基于相差显微评估、DAPI、吖啶橙/溴化乙锭 (AO/EB) 染色和膜联蛋白 V-FITC 测定的进一步研究以了解10 小时的作用机制表明，细胞内 ROS 的升高导致线粒体膜电位反过来诱导 BT-474 癌细胞凋亡，这可能是化合物10h的合理作用机制。
• Compounds for cancer chemotherapeutic sensitization
  申请人：Regents of the University of Minnesota

  公开号：US10617706B2

  公开（公告）日：2020-04-14

  The invention provides a compound of formula (I), (II) or (III): wherein R1, R2, R3, R4 and R5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), (II) or (III). The compounds and compositions are useful as chemotherapeutic sensitizing agents.

  本发明提供了一种式 (I)、(II) 或 (III) 的化合物： 其中 R1、R2、R3、R4 和 R5 具有说明书中描述的任一数值，以及包含式 (I)、(II) 或 (III) 化合物的组合物。这些化合物和组合物可用作化疗增敏剂。
• Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide
  作者：Jayakanth Kankanala、Carlos J. A. Ribeiro、Evgeny Kiselev、Azhar Ravji、Jessica Williams、Jiashu Xie、Hideki Aihara、Yves Pommier、Zhengqiang Wang

  DOI：10.1021/acs.jmedchem.9b00274

  日期：2019.5.9

  Topoisomerase II (TOP2) poisons as anticancer drugs work by trapping TOP2 cleavage complexes (TOP2cc) to generate DNA damage. Repair of such damage by tyrosyl DNA phosphodiesterase 2 (TDP2) could render cancer cells resistant to TOP2 poisons. Inhibiting TDP2, thus, represents an attractive mechanism-based chemosensitization approach. Currently known TDP2 inhibitors lack cellular potency and/or permeability. We report herein two novel subtypes of the deazaflavin TDP2 inhibitor core. By introducing an additional phenyl ring to the N-10 phenyl ring (subtype 11) or to the N-3 site of the deazaflavin scaffold (subtype 12), we have generated novel analogues with considerably improved biochemical potency and/or permeability. Importantly, many analogues of both subtypes, particularly compounds 11a, 11e, 12a, 12b, and 12h, exhibited much stronger cancer cell sensitizing effect than the best previous analogue 4a toward the treatment with etoposide, suggesting that these analogues could serve as effective cellular probes.